|
Market Closed -
NYSE
23:00:03 16/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 340.92 USD | -0.14% |
|
+5.27% | +0.94% |
| 10-16 | UBS Adjusts Price Target on Cencora to $400 From $430, Keeps Buy Rating | MT |
| 10-12 | Baird Adjusts Price Target on Cencora to $373 From $370 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CENCORA, INC. | Other Medical Equipment, Supplies & Distribution | -0.14% | +5.27% | +0.94% | +6.74% | +184.43% | 65.06B |  | |  |
- Stock Market
- Stocks
- COR Stock
- Charts Cencora, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
